Skip to main content

and
  1. No Access

    Chapter

    Restriction Fragment Length Polymorphism of HLA-DR7 Alleles and Association with HLA-B Antigens

    Although HLA-DR7 appears to be serologically homo- 2. geneous (1), it may be split according to epitopes recognized by T cells (Dw7, Dwl1) and is normally found in association with either DQw2 or DQw3. This re...

    Elizabeth A. Bidwell, Jeffrey L. Bidwell, Trevor J. Jones in Immunobiology of HLA (1989)

  2. No Access

    Chapter

    Identification of Dw2, Dw12, and “Short” DR2 Splits with Sequential Exon-Specific DRβ, DQβ, and DQα cDNA Probes

    The HLA-DR2 specificity has been divided by alloantisera (DR2 and “short” DR2) and by T cells (Dw2, Dw12, DB9 (LD-5a), FJO, and LD-MN2). The FJO and LD-MN2 splits appear to correlate with the short DR2 serotyp...

    Jeffrey L. Bidwell, Elizabeth A. Bidwell, David A. Savage in Immunobiology of HLA (1989)

  3. Chapter

    Nucleic Acids-Based Therapeutics in the Battle Against Pathogenic Viruses

    For almost three decades, researchers have studied the possibility to use nucleic acids as antiviral therapeutics. In theory, compounds such as antisense oligonucleotides, ribozymes, DNAzymes, and aptamers can...

    Joost Haasnoot, Ben Berkhout in Antiviral Strategies (2009)

  4. No Access

    Chapter

    Gene Therapy Strategies to Block HIV-1 Replication by RNA Interference

    The cellular mechanism of RNA interference (RNAi) plays an antiviral role in many organisms and can be used for the development of therapeutic strategies against viral pathogens. Persistent infections like the...

    Elena Herrera-Carrillo Ph.D. in Gene Therapy for HIV and Chronic Infections (2015)

  5. Chapter

    Correction to: Application of iPSC to Modelling of Respiratory Diseases

    Ben A. Calvert, Amy L. Ryan (Firth) in Cell Biology and Translational Medicine, Volume 7 (2020)

  6. Chapter

    Application of iPSC to Modelling of Respiratory Diseases

    Respiratory disease is one of the leading causes of morbidity and mortality world-wide with an increasing incidence as the aged population prevails. Many lung diseases are treated for symptomatic relief, with ...

    Ben A. Calvert, Amy L. Ryan (Firth) in Cell Biology and Translational Medicine, Volume 7 (2020)

  7. No Access

    Chapter

    CRISPR-Cas-Based Gene Therapy to Target Viral Infections

    In recent years, there is an increasing demand for the development of new antiviral strategies due to the prevalence of viral infections such as those caused by the human immunodeficiency (HIV) or the hepatiti...

    Mouraya Hussein, Ben Berkhout, Elena Herrera-Carrillo in Biotechnologies for Gene Therapy (2022)